Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Neurodegenerative disease
|
| gptkbp:abbreviation |
gptkb:CBD
|
| gptkbp:affects |
brain
|
| gptkbp:averageOnsetAge |
60
|
| gptkbp:averageSurvival |
6 to 8 years
|
| gptkbp:causedBy |
abnormal tau protein accumulation
|
| gptkbp:characterizedBy |
cognitive impairment
progressive movement disorder asymmetric motor symptoms |
| gptkbp:class |
gptkb:tauopathy
|
| gptkbp:diagnosedBy |
clinical evaluation
MRI PET scan |
| gptkbp:differentialDiagnosis |
gptkb:Alzheimer's_disease
gptkb:Parkinson's_disease gptkb:Progressive_supranuclear_palsy |
| gptkbp:firstDescribed |
1967
|
| https://www.w3.org/2000/01/rdf-schema#label |
Corticobasal Degeneration
|
| gptkbp:ICD-10_code |
G23.8
|
| gptkbp:MeSH_ID |
D020767
|
| gptkbp:OMIM |
600116
|
| gptkbp:prevalence |
rare
|
| gptkbp:prognosis |
progressive and fatal
|
| gptkbp:symptom |
cognitive decline
rigidity dystonia Aphasia myoclonus speech difficulties alien limb phenomenon |
| gptkbp:treatment |
symptomatic management
|
| gptkbp:bfsParent |
gptkb:Atypical_Parkinsonian_Syndromes
|
| gptkbp:bfsLayer |
6
|